BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20447493)

  • 21. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma.
    Ayman T; Yerebakan O; Ciftçioglu MA; Alpsoy E
    Pediatr Dermatol; 2002; 19(5):436-8. PubMed ID: 12383103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
    Otte HG; Stieler W; Anton-Lamprecht I
    Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.
    Montaudié H; Chiaverini C; Sbidian E; Charlesworth A; Lacour JP
    Orphanet J Rare Dis; 2016 Aug; 11(1):117. PubMed ID: 27544590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa.
    Mallipeddi R; Wessagowit V; South AP; Robson AM; Orchard GE; Eady RA; McGrath JA
    J Invest Dermatol; 2004 May; 122(5):1302-9. PubMed ID: 15140235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa: report of eight tumours in four patients.
    Bosch RJ; Gallardo MA; Ruiz del Portal G; Snchez P; Arce MF; Herrera E
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):198-204. PubMed ID: 10642056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dystrophic epidermolysis bullosa with epidermal neoplasms with emphasis on a dermal collagen defect.
    Reed WB; Torres-Rodriguez V; Francis MJ; Ryan T; Torres C
    Birth Defects Orig Artic Ser; 1975; 11(6):153-66. PubMed ID: 1103992
    [No Abstract]   [Full Text] [Related]  

  • 27. MMP13 can be a useful differentiating marker between squamous cell carcinoma and benign hyperkeratotic lesions in recessive dystrophic epidermolysis bullosa.
    Hata H; Abe R; Suto A; Homma E; Fujita Y; Aoyagi S; Shimizu H
    Br J Dermatol; 2015 Mar; 172(3):769-73. PubMed ID: 25066310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry.
    Fine JD; Johnson LB; Weiner M; Stein A; Cash S; Deleoz J; Devries DT; Suchindran C
    Am J Ophthalmol; 2004 Aug; 138(2):254-62. PubMed ID: 15289135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies.
    Newman C; Wagner RF; Tyring SK; Spigel GT
    J Dermatol Surg Oncol; 1992 Apr; 18(4):301-5. PubMed ID: 1560154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous Squamous Cell Carcinoma in Epidermolysis Bullosa: a 28-year Retrospective Study.
    Robertson SJ; Orrin E; Lakhan MK; O'Sullivan G; Felton J; Robson A; Greenblatt DT; Bernardis C; McGrath JA; Martinez AE; Mellerio JE
    Acta Derm Venereol; 2021 Aug; 101(8):adv00523. PubMed ID: 34230977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Rodeck U; Fertala A; Uitto J
    Exp Dermatol; 2007 Jun; 16(6):465-7. PubMed ID: 17518985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of cutaneous pinch grafts in the healing of patients with dystrophic epidermolysis bullosa wounds: report of four cases].
    Claude O; Binder JP; Bustamante K; Blanchet-Bardon C; Andrivon F; Revol M; Servant JM
    Ann Chir Plast Esthet; 2005 Jun; 50(3):189-96. PubMed ID: 15963838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa.
    Tyring SK; Chopra V; Johnson L; Fine JD
    Arch Dermatol; 1989 Jun; 125(6):797-800. PubMed ID: 2730100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa.
    Weber F; Bauer JW; Sepp N; Högler W; Salmhofer W; Hintner H; Fritsch P
    Acta Derm Venereol; 2001; 81(3):189-92. PubMed ID: 11558875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Squamous cell carcinoma developing in a 12-year-old boy with nonHallopeau-Siemens recessive dystrophic epidermolysis bullosa.
    Kawasaki H; Sawamura D; Iwao F; Kikuchi T; Nakamura H; Okubo S; Matsumura T; Shimizu H
    Br J Dermatol; 2003 May; 148(5):1047-50. PubMed ID: 12786841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of gene therapy for recessive dystrophic epidermolysis bullosa.
    Subramaniam KS; Antoniou MN; McGrath JA; Lwin SM
    Br J Dermatol; 2022 Apr; 186(4):609-619. PubMed ID: 34862606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Squamous cell carcinoma complicating an hereditary epidermolysis bullosa].
    Mseddi M; Turki H; Marrekchi S; Abdelmaksoud W; Masmoudi A; Bouassida S; Zahaf A
    Cancer Radiother; 2004 Aug; 8(4):266-9. PubMed ID: 15450521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Squamous cell carcinoma and recessive dystrophic epidermolysis bullosa].
    Fourel E; Claudy AL
    Ann Dermatol Venereol; 1992; 119(8):563-5. PubMed ID: 1485760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs.
    Fine JD; Mellerio JE
    J Am Acad Dermatol; 2009 Sep; 61(3):387-402; quiz 403-4. PubMed ID: 19700011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
    Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
    Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.